Baricitinib Backed for Approval for Alopecia Areata in the EU Baricitinib Backed for Approval for Alopecia Areata in the EU
In February 2022, the FDA granted priority review for baricitinib in adults with severe alopecia areata.International Approvals (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 20, 2022 Category: Internal Medicine Tags: Dermatology News Alert Source Type: news
Baricitinib Promotes Hair Growth in Alopecia Areata Baricitinib Promotes Hair Growth in Alopecia Areata
More than one third of patients who received the high dose of the Janus kinase inhibitor achieved the study goal of approximately 80% hair coverage.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 12, 2022 Category: Allergy & Immunology Tags: Dermatology News Source Type: news
Alopecia Areata: What you need to know
Alopecia Areata is an autoimmune disorder that leads to loss of hair in clumps or patches. (Source: The Economic Times)
Source: The Economic Times - April 18, 2022 Category: Consumer Health News Source Type: news
What you should know about alopecia, the hair loss condition affecting Jada Pinkett Smith
Alopecia areata is the condition affecting Jada Pinkett Smith, who found herself at the center of the Will Smith-Chris Rock conflict at the Oscars ceremony Sunday. Dr. Brett King answers FAQs about the causes, severity, challenges, treatments and more. (Source: CNN.com - Health)
Source: CNN.com - Health - March 29, 2022 Category: Consumer Health News Source Type: news
COVID-19 –Alopecia Areata Link? Review Doesn't Find Much Evidence COVID-19 –Alopecia Areata Link? Review Doesn't Find Much Evidence
Another form of alopecia, however, is more common after COVID-19.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 29, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
Oscars Fight Highlights for Many the Toll Alopecia May Carry Oscars Fight Highlights for Many the Toll Alopecia May Carry
People with alopecia areata are speaking out in support of Jada Pinkett Smith after the Oscar Awards chaos, along with sharing the emotional toll that can come with hair loss.WebMD Health News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 29, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
Oscars Fight Highlights for Many the Toll Alopecia May Carry
Individuals with alopecia areata are speaking out in support of Jada Pinkett Smith amid last night’s Oscar Awards chaos, along with sharing the emotional toll that can come with hair loss. (Source: WebMD Health)
Source: WebMD Health - March 29, 2022 Category: Consumer Health News Source Type: news
AAD: Baricitinib Tops Placebo for Hair Regrowth in Alopecia Areata
MONDAY, March 28, 2022 -- For adults with severe alopecia areata, oral baricitinib is superior to placebo with respect to hair regrowth at 36 weeks, according to a study published online March 26 in the New England Journal of Medicine to coincide... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 28, 2022 Category: Pharmaceuticals Source Type: news
Dramatic, Durable Hair Growth With Oral JAK Inhibitor
(MedPage Today) -- BOSTON -- An oral Janus kinase (JAK) inhibitor produced significant, durable hair growth, including scalp, eyebrows, and eyelashes in patients with severe alopecia areata, according to long-term data from two randomized trials... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 27, 2022 Category: Dermatology Source Type: news
New Trial Data Show Hair Growth in More Alopecia Areata Patients New Trial Data Show Hair Growth in More Alopecia Areata Patients
At 52 weeks, nearly 40% of people taking the higher dose of baricitinib had scalp hair coverage of 80% or more, according to updated clinical trial data.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 27, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
New trials for alopecia areata treatment are a success
One in three patients with severe alopecia areata regrew hair after being treated with the arthritis drug baricitinib. (Source: Yale Science and Health News)
Source: Yale Science and Health News - March 26, 2022 Category: Universities & Medical Training Source Type: news
Latest JAK inhibitor trials for severe skin disease are a success
One in three patients with severe alopecia areata regrew hair after being treated with the arthritis drug baricitinib. (Source: Yale Science and Health News)
Source: Yale Science and Health News - March 26, 2022 Category: Universities & Medical Training Source Type: news
The Epidemiology of Alopecia Areata The Epidemiology of Alopecia Areata
This study elucidates the epidemiology of alopecia areata, focusing on incidence, demographics and patterns of healthcare utilization.The British Journal of Dermatology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 14, 2022 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news
Study: Children With Alopecia Areata Respond to Tofacitinib Study: Children With Alopecia Areata Respond to Tofacitinib
The chart review summarized the results in 11 pediatric patients, ages 8 to 18 years, all with a diagnosis of alopecia areata, who were treated with tofacitinib.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 14, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
How Can I Grow My Hair If I Have Alopecia Areata?
Title: How Can I Grow My Hair If I Have Alopecia Areata?Category: Diseases and ConditionsCreated: 1/3/2022 12:00:00 AMLast Editorial Review: 1/3/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - January 3, 2022 Category: Dermatology Source Type: news
